Related Experiment Videos
[Disturbances of oxidative metabolism in congestive heart failure. Possibility of pharmacologic protection]
J Kowalski1, L Pawlicki, M Kopff
1Kliniki Chorób Płuc, Lodzi.
Abstract:
In 20 patients with congestive heart failure, a significant increase in malonyldialdehyde (MDA) plasma concentration, decrease in GSH-Px plasma activity and decrease in selenium (Se) concentration in plasma and whole blood were found. We discussed possibility of pharmacological protection in observed oxidative metabolism disturbances.
Insights
Congestive heart failure patients showed increased malondialdehyde (MDA) and decreased glutathione peroxidase (GSH-Px) activity and selenium levels. These findings suggest oxidative stress may play a role in heart failure progression.
Area of Science:
- Biochemistry
- Cardiology
- Clinical Medicine
Background:
- Oxidative stress is implicated in various chronic diseases.
- Congestive heart failure (CHF) is a complex syndrome with multifactorial pathophysiology.
- Understanding metabolic disturbances in CHF is crucial for therapeutic development.
Purpose of the Study:
- To investigate oxidative stress markers in patients with congestive heart failure.
- To assess the relationship between malondialdehyde, glutathione peroxidase, and selenium levels in CHF.
- To explore potential pharmacological interventions for oxidative metabolism disturbances in CHF.
Main Methods:
- Blood samples were collected from 20 patients diagnosed with congestive heart failure.
- Plasma malondialdehyde (MDA) concentration was measured.
- Plasma and whole blood selenium (Se) concentrations and plasma glutathione peroxidase (GSH-Px) activity were determined.
Main Results:
- A significant elevation in plasma MDA concentration was observed in CHF patients.
- A significant reduction in plasma GSH-Px activity was found.
- Decreased selenium concentrations were detected in both plasma and whole blood of the study cohort.
Conclusions:
- The study indicates heightened oxidative stress in patients with congestive heart failure.
- Alterations in MDA, GSH-Px, and selenium suggest a role for oxidative metabolism disturbances in CHF.
- Pharmacological strategies targeting oxidative stress warrant further investigation for CHF management.